The DOI matches its Crossref record.
Drugs Which Inhibit Prostaglandin Biosynthesis
Abstract
Three classes of compounds inhibit prostaglandin synthetase. The first group consists of the substrate analogues. The specificity of these analogues is unknown but many possess good inhibitory potency which makes them useful tools to demonstrate the involvement of the synthetase enzyme. However, although they are active in some organised tissue preparations, their use in vivo has not been widespread. The absorption, excretion and distribution of these fatty acids is not yet fully understood and this tends to detract from their usefulness in whole animal work. Apart from the substrate analogues a number of other fatty acids also inhibit the synthetase but probably in a non-specific manner and only in high concentrations. The second class of inhibitors consists of the aspirin-like drugs. Although these may not be as specific as the substrate analogues, they have several advantages; they are readily available, easily administered and in many species abolish prostaglandin synthesis almost completely in therapeutic doses. In addition, a considerable amount is known concerning their absorption, distribution and excretion. The final group of inhibitors which inhibit the synthetase includes such diverse agents as metal ions, anti-oxidants and nucleotides. The concentrations necessary to achieve inhibition are often high and no degree of specificity can be claimed. Thus, these agents are not likely to be of value for in vivo work, although in vitro studies with different cofactors and ions may contribute to our understanding of how the synthetase system is regulated. Concerning the inhibition of the dehydrogenase, the situation is far less clear. Certain substrate analogues appear to be good inhibitors of the purified enzyme, although they have not been tested in vivo. Some of the aspirin-like drugs are also active in this respect, but the concentrations are again rather high. Polyphloretin phosphate inhibits PGDH and on this basis it may be worth investigating other prostaglandin blocking agents or agonists as inhibitors of PGDH. In conclusion, the participation of prostaglandins in complex biological events may be investigated with the aid of substrate analogues or with pharmacological agents which block prostaglandin biosynthesis both in vitro and in vivo. At the time of writing no convenient technique for producing the complementary effect, by inhibition of metabolism, is available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
Mechanism of Action of Anti-Inflammatory Drugs
Vane, J. R., & Botting, R. M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609097226 · Cited by 465
Role of endothelial cells in relaxation of isolated arteries by bradykinin.
Cherry, P. D., Furchgott, R. F., Zawadzki, J. V., & Jothianandan, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2106 · Cited by 425
Rehncrona, S., Westerberg, E., Åkesson, B., & Siesjö, B. K. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb10857.x · Cited by 384
Basic Mechanisms of Prostaglandin Action on Autonomic Neurotransmission
Hedqvist, P. (1977) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.17.040177.001355 · Cited by 329
Metadata
- Authors
- Flower, R. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 1974-03
- Volume
- 26
- Issue
- 1
- Pages
- 33-67
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W1853539513
- Cited by
- 1,323
- References
- 0
- FWCI
- 73.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drugs Which Inhibit Prostaglandin Biosynthesis. https://app.cochat.ai/papers/10.1016/s0031-6997(25)06634-7
- The paper
- Flower, R. J. (1974). Drugs Which Inhibit Prostaglandin Biosynthesis. Pharmacological Reviews. https://doi.org/10.1016/s0031-6997(25)06634-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.